Global Clinical Trial Opportunities in Japan (1)
Since 2007, Japan has been engaged in a sweeping wave of reforms covering the pharmaceutical regulatory environment and the clinical trial infrastructure in order to enable a swift execution of global clinical trials in Japan and eradicate the onerous “drug lag problem” ie delay between launch of a drug in the West (EU/US) and Japan. This first article is an introduction to some unique features of Japanese clinical trial environment and the changes that have been ongoin...
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.